Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation
NCT05474664
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Fontan Operation
Protein-Losing Enteropathy
Camostat Mesylate
Interventions
DRUG:
Camostat mesylate
Sponsor
Seoul National University Hospital